REPORT ID 6130

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017

Publish Date
25-Dec-17
Pages
137
Format
Electronic (PDF)

This report studies the Viral Vectors and Plasmid DNA Manufacturing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Viral Vectors and Plasmid DNA Manufacturing market by product type and applications/end industries.

In the last several years, global market of Viral Vectors and Plasmid DNA Manufacturing developed rapidly, with an average growth rate of 28.05%. In 2016, global revenue of Viral Vectors and Plasmid DNA Manufacturing is nearly 250 M USD. 

The major players in global Viral Vectors and Plasmid DNA Manufacturing market include 
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory

Geographically, this report is segmented into several key Regions, with revenue, Market Share and Growth Rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Viral Vectors and Plasmid DNA Manufacturing market is primarily split into 
Plasmid DNA
Viral Vectors 


On the basis on the end users/applications, this report covers 
Cancers
Inherited Disorders
Viral Infections
Other

 
 
			   
Table of Contents

1 Viral Vectors and Plasmid DNA Manufacturing Market Overview	1
1.1 Viral Vectors and Plasmid DNA Manufacturing Product Overview	1
1.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Types (Product Category)	1
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Comparison by Types (2012-2022)	1
1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Types in 2016	2
1.2.3 Viral Vectors	3
1.2.4 Plasmid DNA	3
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Segment by Applications	4
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Applications (2012-2022)	4
1.3.2 Cancers	5
1.3.3 Inherited Disorders	6
1.3.4 Viral Infections	7
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions (2012-2022)	8
1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Comparison by Regions (2012-2022)	8
1.4.2 North America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	9
1.4.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	10
1.4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	11
1.4.5 South America Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	12
1.4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2012-2022)	13
1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (2012-2022)	14
2 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers/Brand	15
2.1 Global Viral Vectors Manufacturing Revenue and Share by Manufacturers (2016-2017)	15
2.2 Global Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2016-2017)	17
2.3 Global Viral Vectors and Plasmid DNA Manufacturing Gross Margin by Manufacturers (2016-2017)	19
2.4 Manufacturers Viral Vectors and Plasmid DNA Manufacturing Headquarters, Established Date, Product Types	21
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends	22
2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate	22
2.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Manufacturers	23
2.5.3 Mergers & Acquisitions, Expansion	24
3 Global Viral Vectors and Plasmid DNA Manufacturing, Revenue by Regions (2012-2017)	27
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions (2012-2017)	27
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	29
3.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	29
3.4 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	30
3.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	30
3.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	31
3.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Profit, Cost and Gross Margin (2012-2017)	31
4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue, Growth Trend by Types	32
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Types (2012-2017)	32
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Growth by Type (2012-2017)	34
5 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications	35
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Applications (2012-2017)	35
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Applications (2012-2017)	37
6 Analysis of Viral Vectors and Plasmid DNA Manufacturing Industry Key Manufacturers	38
6.1 BioReliance	38
6.1.1 Company Profile	38
6.1.2 Product Information	40
6.1.3 Revenue, Cost, Gross Profit and Gross Margin	40
6.2 Cobra Biologics	40
6.2.1 Company Profile	40
6.2.2 Product Information	42
6.2.3 Revenue, Cost, Gross Profit and Gross Margin	42
6.3 Oxford BioMedica	43
6.3.1 Company Profile	43
6.3.2 Product Information	44
6.3.3 Revenue, Cost, Gross Profit and Gross Margin	44
6.4 UniQure	45
6.4.1 Company Profile	45
6.4.2 Product Information	46
6.4.3 Revenue, Cost, Gross Profit and Gross Margin	46
6.5 FinVector	47
6.5.1 Company Profile	47
6.5.2 Product Information	48
6.5.3 Revenue, Cost, Gross Profit and Gross Margin	48
6.6 MolMed	49
6.6.1 Company Profile	49
6.6.2 Product Information	50
6.6.3 Revenue, Cost, Gross Profit and Gross Margin	51
6.7 MassBiologics	51
6.7.1 Company Profile	51
6.7.2 Product Information	52
6.7.3 Revenue, Cost, Gross Profit and Gross Margin	52
6.8 Richter-Helm	53
6.8.1 Company Profile	53
6.8.2 Product Information	54
6.8.3 Revenue, Cost, Gross Profit and Gross Margin	55
6.9 FUJIFILM Diosynth Biotechnologies	55
6.9.1 Company Profile	55
6.9.2 Product Information	56
6.9.3 Revenue, Cost, Gross Profit and Gross Margin	57
6.10 Lonza	57
6.10.1 Company Profile	57
6.10.2 Product Information	58
6.10.3 Revenue, Cost, Gross Profit and Gross Margin	59
6.11 Aldevron	59
6.11.1 Company Profile	59
6.11.2 Product Information	60
6.11.3 Revenue, Cost, Gross Profit and Gross Margin	60
6.12 Eurogentec	61
6.12.1 Company Profile	61
6.12.2 Product Information	62
6.12.3 Revenue, Cost, Gross Profit and Gross Margin	62
6.13 Cell and Gene Therapy Catapult	62
6.13.1 Company Profile	62
6.13.2 Product Information	64
6.13.3 Revenue, Cost, Gross Profit and Gross Margin	64
6.14 Biovian	64
6.14.1 Company Profile	64
6.14.2 Product Information	65
6.14.3 Revenue, Cost, Gross Profit and Gross Margin	66
6.15 Brammer Bio	66
6.15.1 Company Profile	66
6.15.2 Product Information	68
6.15.3 Revenue, Cost, Gross Profit and Gross Margin	68
6.16 VGXI	69
6.16.1 Company Profile	69
6.16.2 Product Information	70
6.16.3 Revenue, Cost, Gross Profit and Gross Margin	71
6.17 PlasmidFactory	71
6.17.1 Company Profile	71
6.17.2 Product Information	72
6.17.3 Revenue, Cost, Gross Profit and Gross Margin	73
7 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis	74
7.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis	74
7.1.1 Key Raw Materials	74
7.1.2 Key Suppliers of Raw Materials	75
7.2 Proportion of Manufacturing Cost Structure	77
7.2.1 Raw Materials	77
7.2.2 Labor Cost Analysis	78
7.2.2.1 USA Labor Cost Analysis	78
7.2.2.2 Europe Labor Costs Analysis	79
7.2.2.3 Asia Labor Costs Analysis	81
7.2.3 Other Costs Analysis	82
7.2.3.1 USA Cost of Electricity Analysis	82
7.2.3.2 USA Water Cost Analysis	82
7.2.3.3 Europe Cost of Electricity Analysis	83
7.2.3.4 Europe Water Cost Analysis	84
7.2.3.5 China Cost of Electricity Analysis	85
7.2.3.6 China Water Cost Analysis	86
7.2.4 Manufacturing Expenses	86
7.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing	87
8 Industrial Chain, Sourcing Strategy and Downstream Buyers	88
8.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis	88
8.2 Upstream Raw Materials Sourcing	89
8.3 Downstream Buyers	89
9 Marketing Strategy Analysis, Distributors/Traders	92
9.1 Marketing Channel	92
9.1.1 Direct Marketing	92
9.1.2 Indirect Marketing	92
9.1.3 Marketing Channel Development Trend	93
9.2 Market Positioning	93
9.2.1 Pricing Strategy	93
9.2.2 Brand Strategy	94
9.2.3 Target Client	96
10 Market Effect Factors Analysis	97
10.1 Technology Progress in Related Industry	97
10.2 Consumer Needs/Customer Preference Change	98
10.3 Economic/Political Environmental Change	98
11 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)	107
11.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	107
11.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Regions (2017-2022)	108
11.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	109
11.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing and Revenue Forecast (2017-2022)	110
11.2.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	111
11.2.4 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	112
11.2.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast (2017-2022)	113
11.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Type (2017-2022)	113
11.4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Application (2017-2022)	114
12 Research Findings and Conclusion	116
13 Methodology and Data Source	117
13.1 Methodology/Research Approach	117
13.1.1 Research Programs/Design	117
13.1.2 Market Size Estimation	118
13.1.3 Market Breakdown and Data Triangulation	119
13.2 Data Source	120
13.2.1 Secondary Sources	120
13.2.2 Primary Sources	121
13.3 Disclaimer	122
13.4 Author List	123